Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Development of New Vaccines against Dengue Fever and Japanese Encephalitis

1 Jan 2001

Abstract excerpt

Mosquito-borne dengue (DEN) and Japanese encephalitis (JE) viruses are the leading causes of arthropod-transmitted viral disease in humans. A licensed tetravalent vaccine that provides effective, long-term immunity against all four serotypes of DEN virus is needed, but is currently unavailable. Improvements to currently available JE vaccines are also needed. Past and recent strategies for the development of new...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Insect symbiosis and bacterial influences
Share to Mosquito-borne diseases and control
Share to Viral Infections and Vectors

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 11509879
DOI: 10.1159/000050045

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Development of New Vaccines against Dengue Fever and Japanese EncephalitisPMID 11509879Read ↗

Traditional and novel approaches to flavivirus vaccines.Semantic proximity Read ↗

A Chimeric Dengue Virus Vaccine using Japanese Encephalitis Virus Vaccine Strain SA14-14-2 as Backbone Is Immunogenic and Protective against Either Parental Virus in Mice and Nonhuman PrimatesSemantic proximity Read ↗

Japanese encephalitis vaccines: Immunogenicity, protective efficacy, effectiveness, and impact on the burden of disease.Semantic proximity Read ↗

From the World Health Organization. Development of dengue and Japanese encephalitis vaccines.Semantic proximity Read ↗

Japanese encephalitis virus vaccine candidates generated by chimerization with dengue virus type 4.Semantic proximity Read ↗

Approaches of dengue control: vaccine strategies and future aspectsSemantic proximity Read ↗

Preclinical and clinical development of YFV 17D-based chimeric vaccines against dengue, West Nile and Japanese encephalitis virusesSemantic proximity Read ↗

Development of a Recombinant Vaccine Against Japanese EncephalitisSemantic proximity Read ↗

Development of a Live Attenuated Dengue Virus Vaccine Using Reverse GeneticsSemantic proximity Read ↗

Protective Efficacy of a Chimeric Insect-Specific Flavivirus Vaccine against West Nile VirusSemantic proximity Read ↗

A heterologous virus-vectored vaccine for prevention of Middle East respiratory syndrome induces long protective immune response against MERS-CoVSemantic proximity Read ↗

The development of recombinant subunit envelope-based vaccines to protect against dengue virus induced diseaseSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.